Ranbaxy launches generic atorvastatin in South Africa
This article was originally published in Scrip
Ranbaxy Laboratories has launched its generic version of Pfizer’s top-selling lipid-lowerer, Lipitor (atorvastatin), on the South African market. The launch comes weeks after Ranbaxy introduced generic atorvastatin in Canada.
You may also be interested in...
Tildrakizumab debuts in Japan, marking a key milestone for Sun Pharma, though heavyweight competitors including same class rival Skyrizi are already available on the market there.
Redirection of healthcare resources to tackle COVID-19 is posing huge challenges for TB care and researchers in the area. Companies like J&J have stepped in to support, among other aspects, innovative community-based solutions to ensure continuity of care for drug resistant-TB patients amid the pandemic.
The former CEO of Cipla’s India business is set to steer JB Chemicals and Pharmaceuticals, as the Indian firm embarks on a new phase of growth, backed by a revamped board, following its takeover by US private equity firm KKR.